RA Capital Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.2M | Hold |
6,147,280
| – | – | 1.4% | 20 |
|
|
2025
Q1 | $97.6M | Buy |
6,147,280
+1,296,296
| +27% | +$20.6M | 1.63% | 16 |
|
|
2024
Q4 | $59.7M | Hold |
4,850,984
| – | – | 0.79% | 26 |
|
|
2024
Q3 | $58.7M | Hold |
4,850,984
| – | – | 0.68% | 32 |
|
|
2024
Q2 | $56.8M | Hold |
4,850,984
| – | – | 0.75% | 34 |
|
|
2024
Q1 | $62.6M | Buy |
4,850,984
+1,672,508
| +53% | +$21.6M | 0.8% | 33 |
|
|
2023
Q4 | $27.3M | Hold |
3,178,476
| – | – | 0.43% | 42 |
|
|
2023
Q3 | $30.2M | Hold |
3,178,476
| – | – | 0.6% | 43 |
|
|
2023
Q2 | $54.2M | Hold |
3,178,476
| – | – | 1.02% | 30 |
|
|
2023
Q1 | $49.8M | Buy |
+3,178,476
| New | +$49.8M | 1.13% | 30 |
|